These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 22200553

  • 21. Development and validation of a liquid chromatography-mass spectrometry metabonomic platform in human plasma of liver failure caused by hepatitis B virus.
    Zhang L, Jia X, Peng X, Ou Q, Zhang Z, Qiu C, Yao Y, Shen F, Yang H, Ma F, Wang J, Yuan Z.
    Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):688-98. PubMed ID: 20810534
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [Abstract] [Full Text] [Related]

  • 23. Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, Ikeda S, Hirayama A, Yamamoto T, Yoshida H, Otsuka M, Tsuji S, Yatomi Y, Sakuragawa T, Watanabe H, Nihei K, Saito T, Kawata S, Suzuki H, Tomita M, Suematsu M.
    J Hepatol; 2011 Oct; 55(4):896-905. PubMed ID: 21334394
    [Abstract] [Full Text] [Related]

  • 24. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY, Li N, Ding HG, Jiang FF.
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [Abstract] [Full Text] [Related]

  • 25. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Dec; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 26. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W.
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
    [Abstract] [Full Text] [Related]

  • 27. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.
    Li S, Liu H, Jin Y, Lin S, Cai Z, Jiang Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug 15; 879(24):2369-75. PubMed ID: 21763219
    [Abstract] [Full Text] [Related]

  • 28. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
    Wu FX, Wang Q, Zhang ZM, Huang S, Yuan WP, Liu JY, Ban KC, Zhao YN.
    Cancer Lett; 2009 Jul 08; 279(2):163-70. PubMed ID: 19268439
    [Abstract] [Full Text] [Related]

  • 29. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 08; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 30. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 08; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 31. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar 08; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 32. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP.
    J Proteome Res; 2005 Mar 08; 4(6):2062-9. PubMed ID: 16335951
    [Abstract] [Full Text] [Related]

  • 33. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.
    Inagaki Y, Xu HL, Hasegawa K, Aoki T, Beck Y, Sugawara Y, Tang W, Kokudo N.
    J Dig Dis; 2011 Dec 08; 12(6):481-8. PubMed ID: 22118699
    [Abstract] [Full Text] [Related]

  • 34. Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.
    Mizuno H, Honda M, Shirasaki T, Yamashita T, Yamashita T, Mizukoshi E, Kaneko S.
    Liver Int; 2012 Aug 08; 32(7):1146-55. PubMed ID: 22372738
    [Abstract] [Full Text] [Related]

  • 35. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.
    Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221
    [Abstract] [Full Text] [Related]

  • 36. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G.
    Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222
    [Abstract] [Full Text] [Related]

  • 37. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
    Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM.
    J Hepatol; 2005 Dec 15; 43(6):1007-12. PubMed ID: 16137783
    [Abstract] [Full Text] [Related]

  • 38. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach.
    Liang Q, Liu H, Wang C, Li B.
    Sci Rep; 2016 Jan 25; 6():19763. PubMed ID: 26805550
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.
    Minerva Med; 2011 Oct 25; 102(5):363-71. PubMed ID: 22193346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.